{"filing":{"accession_number":"0001193125-26-384527","cik":"0001921865","ticker":"ASPI","company_name":"ASP Isotopes Inc.","form":"8-K","filing_date":"2026-09-08","report_date":"2026-09-08","primary_document":"aspi-20260908.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1921865/000119312526384527/aspi-20260908.htm"},"events":[{"id":31876,"run_id":29275,"accession_number":"0001193125-26-384527","anchor_item_number":"7.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"ASP Isotopes disclosed its inaugural Capital Markets Day event in London on September 8, 2026, where management outlined strategy across multiple business segments (nuclear medicine, electronics, helium/LNG, nuclear fuels) and provided operational updates on commercialization progress, including expected revenue growth from liquid helium production and stable isotope shipments, plus a long-term EBITDA target of $300 million by 2031. This is a strategic business communication disclosing material operational milestones and forward guidance, but does not fit the specific categories of earnings release, M\u0026A, debt issuance, or other defined event types—making it an operational disclosure of strategic importance to investors.","company_name":"ASP Isotopes Inc.","ticker":"ASPI","filing_date":"2026-09-08","form":"8-K","submitted_at":null,"items":[{"id":34904,"accession_number":"0001193125-26-384527","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"ASP Isotopes disclosed its inaugural Capital Markets Day event in London on September 8, 2026, where management outlined strategy across multiple business segments (nuclear medicine, electronics, helium/LNG, nuclear fuels) and provided operational updates on commercialization progress, including expected revenue growth from liquid helium production and stable isotope shipments, plus a long-term EBITDA target of $300 million by 2031. This is a strategic business communication disclosing material operational milestones and forward guidance, but does not fit the specific categories of earnings release, M\u0026A, debt issuance, or other defined event types—making it an operational disclosure of strategic importance to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T13:21:38.615437+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":34904,"accession_number":"0001193125-26-384527","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"ASP Isotopes disclosed its inaugural Capital Markets Day event in London on September 8, 2026, where management outlined strategy across multiple business segments (nuclear medicine, electronics, helium/LNG, nuclear fuels) and provided operational updates on commercialization progress, including expected revenue growth from liquid helium production and stable isotope shipments, plus a long-term EBITDA target of $300 million by 2031. This is a strategic business communication disclosing material operational milestones and forward guidance, but does not fit the specific categories of earnings release, M\u0026A, debt issuance, or other defined event types—making it an operational disclosure of strategic importance to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T13:21:38.615437+00:00","company_name":"ASP Isotopes Inc.","ticker":"ASPI","filing_date":"2026-09-08"}]}